ALLMedicine™ Hepatitis B Virus Center
Research & Reviews 3,415 results
https://doi.org/10.1111/apt.16659
Alimentary Pharmacology & Therapeutics; Vittal A, Sharma D et. al.
Dec 2nd, 2021 - Although hepatitis B surface antigen (HBsAg) loss is considered the ideal therapeutic endpoint for the treatment of chronic hepatitis B virus (HBV) infection, its impact on clinical outcomes remains uncertain. To assess the impact of HBsAg loss on...
https://doi.org/10.1186/s12985-021-01706-w 10.1056/NEJMra031087 10.1111/j.1537-2995.2009.02322.x 10.1111/j.1537-2995.2011.03355.x 10.1016/j.jcv.2018.05.009 10.1016/j.diagmicrobio.2020.115033 10.1111/trf.12218 10.1002/hep.30082 10.1046/j.1537-2995.2003.00424.x 10.1016/j.jcv.2019.08.001 10.1002/cld.774 10.3390/v13060951 10.1016/j.jhep.2010.01.014 10.1111/j.1537-2995.2009.02195.x 10.1046/j.1537-2995.2001.41030329.x 10.1016/j.jhep.2017.03.021 10.1093/infdis/jit563
Virology Journal; Kuhns MC, Holzmayer V et. al.
Dec 1st, 2021 - Hepatitis B virus (HBV) serum markers during typical acute self-limited infection are usually depicted as a composite of traditional HBV markers. The current study updates and expands our knowledge of acute hepatitis B with quantitative molecular ...
https://doi.org/10.1186/s12985-021-01707-9 10.1056/NEJMra0801644 10.1016/j.jhep.2003.12.002 10.1056/NEJM199910213411702 10.1056/NEJMoa012452 10.1016/j.jpeds.2004.05.046 10.1002/hep.30050 10.1097/01.mpg.0000243439.47334.4e 10.1111/jvh.13165 10.1111/jvh.13154 10.1016/j.jpeds.2005.09.020 10.1111/jvh.12007 10.1016/j.jhep.2018.01.037 10.1016/j.jhep.2019.07.022 10.1128/JVI.79.5.3071-3083.2005 10.1016/j.jhep.2008.12.018 10.1136/gut.2010.226225 10.1002/hep.21374 10.1136/gutjnl-2019-318278 10.1016/j.vaccine.2017.10.032 10.1053/j.gastro.2006.01.011 10.1016/j.cmi.2014.10.007 10.1016/j.jinf.2017.04.012 10.3748/wjg.v24.i16.1708 10.1111/jgh.12831 10.1016/S0140-6736(95)92599-6 10.1016/j.jhep.2004.01.019 10.1136/gutjnl-2016-312162
Virology Journal; Li Y, Xiao Y et. al.
Dec 1st, 2021 - Previous works have observed that younger infants with chronic hepatitis B virus (HBV) infection are more responsive to antiviral treatment. However, the underlying mechanism remains unclear. In this study, the dynamic changes of HBV quasispecies ...
https://doi.org/10.1080/1061186X.2021.2009841
Journal of Drug Targeting; Yu L, Zeng Z et. al.
Dec 1st, 2021 - Until now, the metabolic effects of hepatitis B virus (HBV) replication on the progression of hepatic diseases (hepatitis, cirrhosis, and liver cancer) and liver functions have remained unexplored. Thus, a total of 199 hepatic disease patients wit...
https://doi.org/10.1111/liv.15124
Liver International : Official Journal of the Internation... Schemmer P, Burra P et. al.
Dec 1st, 2021 - Chronic hepatitis B virus (HBV) infection is the major aetiology of hepatocellular carcinoma (HCC). The optimal goal of therapy, hepatitis B surface antigen (HBsAg) loss and anti-HBs production, is achieved rarely and HBsAg-associated HCC risk is ...
Guidelines 4 results
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.
Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...
https://doi.org/10.1200/JCO.20.01757
Journal of Clinical Oncology : Official Journal of the Am... Hwang JP, Feld JJ et. al.
Jul 28th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management. All patients anticipating systemic anticancer therapy should be tested for HBV by 3 tests-hepatitis B surface an...
https://doi.org/10.1080/23744235.2019.1675903
Infectious Diseases (London, England); Westin J, Aleman S et. al.
Oct 16th, 2019 - Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection remains a major health issue worldwide. HBV is highly infectious and may cause chronic infection, progressive liver damage, hepatocellular cancer (HCC) and...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837403
MMWR. Recommendations and Reports : Morbidity and Mortali... Schillie S, Vellozzi C et. al.
Jun 26th, 2018 - HEPATITIS B VIRUS (HBV) IS TRANSMITTED VIA BLOOD OR SEXUAL CONTACT. PERSONS WITH CHRONIC HBV INFECTION ARE AT INCREASED RISK FOR CIRRHOSIS AND LIVER CANCER AND REQUIRE MEDICAL CARE. THIS REPORT UPDATES AND SUMMARIZES PREVIOUSLY PUBLISHED RECOMMEND...
Drugs 13 results see all →
News 161 results
https://www.medscape.com/viewarticle/960518
Oct 8th, 2021 - The prehistoric origins of the hepatitis B virus are painted in new color by a new study analyzing the largest ever dataset of ancient viral genomes. What to know: The hepatitis B virus (HBV) has been infecting humans for millennia, according to D...
https://www.medscape.com/viewarticle/958869
Sep 16th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Patients with rheumatoid arthritis in remission had a rate of flare following vaccination with the Pfizer/BioNtech COVID-19 vaccine that appears t...
https://www.medscape.com/viewarticle/956348
Aug 10th, 2021 - People beginning treatment with the immunosuppressive drugs tocilizumab (Actemra, Genentech USA Inc) or tofacitinib (Xeljanz, Pfizer Inc) are infrequently screened for hepatitis B virus (HBV) infection, according to a new study of patients with rh...
https://www.medscape.com/viewarticle/955063
Jul 21st, 2021 - NEW YORK (Reuters Health) - RO7049389, a hepatitis B virus (HBV) core protein allosteric modulator, appears safe and shows antiviral action in patients with chronic HBV infection, according to a small company-funded study. "These results provide p...
https://www.medscape.com/viewarticle/952116
Jun 1st, 2021 - NEW YORK (Reuters Health) - A tri-antigenic hepatitis B vaccine (TAV) effectively prevented hepatitis B virus (HBV) infection in adults, was somewhat more effective than a mono-antigenic vaccine (MAV) comparator, but had higher side effect rates i...
